➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Medtronic
AstraZeneca
Harvard Business School
Moodys

Last Updated: June 1, 2020

DrugPatentWatch Database Preview

Actavis Elizabeth Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACTAVIS ELIZABETH, and what generic and branded alternatives to ACTAVIS ELIZABETH drugs are available?

ACTAVIS ELIZABETH has one hundred and sixteen approved drugs.

There are seven tentative approvals on ACTAVIS ELIZABETH drugs.

Summary for Actavis Elizabeth
US Patents:0
Tradenames:75
Ingredients:75
NDAs:116
Patent Litigation for Actavis Elizabeth: See patent lawsuits for Actavis Elizabeth

Drugs and US Patents for Actavis Elizabeth

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth DIAZEPAM diazepam TABLET;ORAL 070707-001 Mar 19, 1986 DISCN No No   Start Trial   Start Trial
Actavis Elizabeth CHLORZOXAZONE chlorzoxazone TABLET;ORAL 040113-001 Sep 29, 1995 DISCN No No   Start Trial   Start Trial
Actavis Elizabeth ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET, EXTENDED RELEASE;ORAL 090869-001 May 17, 2012 AB RX No No   Start Trial   Start Trial
Actavis Elizabeth QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 076459-002 Dec 22, 2004 DISCN No No   Start Trial   Start Trial
Actavis Elizabeth OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 076636-002 Feb 6, 2004 AB RX No No   Start Trial   Start Trial
Actavis Elizabeth MORPHINE SULFATE morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 079040-001 Jan 16, 2013 RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
McKesson
McKinsey
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.